about
The first clinical case due to AP92 like strain of Crimean-Congo Hemorrhagic Fever virus and a field surveyCrimean-Congo hemorrhagic fever infections reported by ProMEDPredictors of fatality in pandemic influenza A (H1N1) virus infection among adults.Imported Crimean-Congo hemorrhagic fever cases in IstanbulTreatment of Crimean-Congo hemorrhagic fever.Crimean-Congo hemorrhagic fever among health care workers, Turkey.Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries.Preparing clinicians for (re-) emerging arbovirus infectious diseases in Europe.An unexpected tetanus case.Who can get the next Nobel Prize in infectious diseases?Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.Widal test in diagnosis of typhoid fever in Turkey.Cytokine response in crimean-congo hemorrhagic fever virus infection.How to Tackle Natural Focal Infections: From Risk Assessment to Vaccination Strategies.Crimean-Congo hemorrhagic fever: aid of abdominal ultrasonography in prediction of severity.Potential sexual transmission of Crimean-Congo hemorrhagic fever infection.Diagnostic contribution of (18)F-FDG-PET/CT in fever of unknown origin.West nile virus infection in the Mesopotamia region, Syria border of Turkey.Health-related quality of life and the prevalence of post-traumatic stress disorder among Crimean-Congo hemorrhagic fever survivors.Crimean-Congo hemorrhagic fever in European part of Turkey: genetic analysis of the virus strains from ticks and a seroepidemiological study in humans.Crimean-Congo hemorrhagic fever in children.Modeling the spatial distribution of crimean-congo hemorrhagic fever outbreaks in Turkey.The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region.Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever.The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli.Revisiting detachment techniques in human-biting ticks.Molecular Epidemiology of Bloodstream Associated E. coli ST131 H30-Rx Subclone Infection in a Region with High Quinolone Resistance.Screening Household Members of Acute Brucellosis Cases in Endemic Areas and Risk Factors for Brucellosis.On the uniqueness of epidemic models fitting a normalized curve of removed individuals.Detailed analysis of diffuse large B cell lymphoma patients: a single-center, retrospective studyRisk factors for occupational brucellosis among veterinary personnel in Turkey.Transmission of methicillin-sensitive Staphylococcus aureus to a preterm infant through breast milk.Neurobrucellosis: clinical and diagnostic features.Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations.Characteristics of cutaneous anthrax in Turkey.The evolving role of PET/CT in fever of unknown origin.Emerging souvenirs - clinical presentation of the returning traveller with imported arbovirus infections in Europe.The rapid diagnosis of viral respiratory tract infections and its impact on antimicrobial stewardship programs.Implementation of an antimicrobial stewardship program for patients with febrile neutropenia.Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection.
P50
Q27488819-ABC8ABE0-8257-4EB7-BD49-95E72BD38DD5Q28242424-BFCDA094-C0FC-4632-846C-293716C2B0A6Q30363464-14DBC801-13BE-4E69-BC27-4EDB57BDEB20Q33286943-310FEA02-1282-4FA0-B327-936137D8A548Q37039152-BDAE954E-04E4-41F2-A6DD-2CAFBD27BD98Q37621688-49C66D2D-CB2E-4088-8C82-935F53A9C213Q38000641-C3E41494-7B5D-4640-9099-57AF2814C9D9Q38158495-0DE14402-9EE9-4534-AD83-8E1986587CF9Q38865316-9794BC03-1D4C-4CB9-876F-13E9F7A1C2D1Q38899470-A810E535-65D9-48F3-9856-20044842FBC4Q39101630-3F38DC8D-193A-4B3F-AFC5-18FE59847F62Q39625987-32B20E7B-0666-4CFC-957F-594709A3275BQ40055332-4463F307-C7A6-4889-AB3D-BBF13CE05068Q40068426-B6D9CCAC-ED3C-4975-A103-0D882B20D3DBQ40182419-69A80319-56FB-4EBD-9A75-588B4E8E5022Q40213756-FF012FA0-21FF-4A0A-B415-ABF66A49C62FQ40226325-3E59B736-EC8F-415A-B5A0-81CC2801DB5EQ40242904-A2ADB14C-7F6F-49B8-9032-6833C0F15F0BQ40273726-DAC0CEFB-FC26-4157-A81C-D28F4186C8ACQ40345121-C44F23CA-EF7A-4070-9308-BD334D3D1D7EQ40359577-0DDBDBD9-8C82-4763-99A7-2A2FEE018777Q40433300-528EE078-8BF8-4916-BD37-9EF4B4D87AB5Q40482021-96017083-6727-4079-A19A-992C8D60BBACQ40484647-39022C5B-60EC-4445-935D-00DE23DB6839Q40607071-B3BB0DA8-0A4A-4F71-9082-C44D12CA3917Q40767247-526F7DF0-2660-42FD-83AE-03FC67D6EBDBQ40822696-B3F19C0D-3001-4CC9-9415-DAF4B7A1D621Q41052159-68F95E2A-D9B2-4C69-A01C-1491BD1FF057Q41702761-D290F272-1A2E-46B3-B47A-E27CFBFB011FQ42104119-20AA15D0-FD8D-4462-8724-A9CE96105E37Q42201489-695B4008-6F90-478D-8119-E470E9D41B26Q42257320-F8FA400F-FB91-4E9B-BE64-225D9C897D88Q42273097-9099DB15-8BE8-4D57-AC9A-24399A8E50AEQ42674435-F78AB19E-A14D-4630-8871-AC3A015C91BAQ43267470-2B53D0E3-E243-4FC7-97F7-39DE5E688EB6Q44158683-51668839-8956-4687-9C30-325F1905FA7EQ47552871-D1791AFB-C8DD-4921-81A7-BABE80853A17Q47553878-40499ED1-D48F-477C-BF67-488C24F2D8F4Q49647205-1064EE60-FFC3-402A-9A95-7F0973EB3BEEQ50133078-BDF46A7F-DC13-426D-8885-A07CB89778C6
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Onder Ergonul
@ast
Onder Ergonul
@en
Onder Ergonul
@es
Onder Ergonul
@nl
Onder Ergonul
@sl
type
label
Onder Ergonul
@ast
Onder Ergonul
@en
Onder Ergonul
@es
Onder Ergonul
@nl
Onder Ergonul
@sl
prefLabel
Onder Ergonul
@ast
Onder Ergonul
@en
Onder Ergonul
@es
Onder Ergonul
@nl
Onder Ergonul
@sl
P106
P108
P31
P496
0000-0003-1935-9235